Obetic

Obeticholic Acid INN

Composition:Obetic-5 Tablet: Each film coated tablet contains Obeticholic Acid INN 5 mg.

Obetic-10 Tablet: Each film coated tablet contains Obeticholic Acid INN 10 mg.

Indications:Obeticholic acid is indicated for the treatment of adultpatients with primary biliary cholangitis (PBC) without cirrhosis or with compensated cirrhosis who do not have evidence of portal hypertension, Either in combination with Ursodeoxycholic Acid (UDCA) with an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA.

Dosage and administration: The usual starting dosage for PBC patients without cirrhosis or with compensated cirrhosis who do not have evidence of portal hypertension who have not achieved an adequate biochemical response to an appropriate dosage of Ursodeoxycholic Acid (UDCA) for at least 1 year or are intolerant to UDCA follows bellow:
Start with dosage of 5mg once daily for first 3 months. After 3 months, for patients who have not achieved adequate reduction in Alkaline phosphate (ALP) and/or total bilirubin and who are tolerating Obeticholic Acid increase to the maximum dosage 10 mg once daily.

Management of patient with intolerable pruritus: Add an antihistamine or bile acid binding resin. Reduce the dosage to 5 mg every other day, for patients intolerable to 5 mg once daily, 5 mg once daily, for patients intolerant to 10 mg once daily. Temporarily interrupt dosing for up to 2 weeks followed by restart at a reduced dosage and titrate the dosage to 10 mg once daily based on biochemical response. Or, as directed by the registered physician.

Use in pregnancy and lactation: The limited available human data on the use of obeticholicacid during pregnancy are not sufficient to inform a drug-associated risk. There is no information on the presence of obeticholic acid in human milk, the effects on the breast-fed infant or the effects on milk production.

Packing: Obetic-5 Tablet: Each box contains 2 x 10's tablets in blister pack.Obetic-10 Tablet: Each box contains 1 x 10's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.